← Leaderboards
Dennis Klinman
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoResponseMicroarray AnalysisLigandsOligonucleotidesImmune ResponsePredispositionCellsGenesInflammatoryImmunosuppressive AgentsTumorImmunePatternMalignant NeoplasmsIn VitroCell TypeAntigensAnimalsProductionChemokineInterestMalignant Neoplasm Of LungCytokine
Grant awards (26)
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$720,328
ZIA · FY2019 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$240,109
ZIA · FY2019 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$837,803
ZIA · FY2018 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$279,268
ZIA · FY2018 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$1,037,336
ZIA · FY2017 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$345,778
ZIA · FY2017 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$1,124,257
ZIA · FY2016 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$374,753
ZIA · FY2016 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$1,054,354
ZIA · FY2015 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$351,451
ZIA · FY2015 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$1,008,580
ZIA · FY2014 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$336,193
ZIA · FY2014 · CA · contact PI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides$1,085,319
ZIA · FY2013 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$361,773
ZIA · FY2013 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$1,124,689
ZIA · FY2012 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$374,896
ZIA · FY2012 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$1,015,446
ZIA · FY2011 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$338,482
ZIA · FY2011 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$1,119,073
ZIA · FY2010 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$373,025
ZIA · FY2010 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$1,209,238
ZIA · FY2009 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$403,079
ZIA · FY2009 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$1,125,031
Z01 · FY2008 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$375,010
Z01 · FY2008 · CA · contact PI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo$760,248
Z01 · FY2007 · CA · contact PI
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide$325,821
Z01 · FY2007 · CA · contact PI